Skip to content
Screener

Rogers Corporation ROG Total Liabilities & Equity

Total Liabilities & Equity at other companies

3M logo
3MMMM
$34.92B-8.1%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$782.35M+13.0%
Biogen logo
BiogenBIIB
$32.09B+13.3%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$792.26M+57.6%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$21.45B-40.4%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$183.97M-24.2%

Other financials

Income statement

See full
Revenue$216.8M+6.9%
Gross profit$70.4M+10.0%
Operating income$20.0M+130%
Net income$13.6M+118%
EPS (diluted)$0.76+119%

Balance sheet

See full
Cash & equivalents$181.4M+15.4%
Total debt$28.5M-14.2%
Total equity$1.2B-0.2%
Total assets$1.4B-0.3%

Cash flow

See full
Operating cash flow$24.4M+78.1%
CapEx$6.1M-24.7%
Free cash flow$18.3M+227%

Valuation

See full
Market cap$2.39B+87.0%
Enterprise value$2.24B+93.9%
P/E89.5×
P/S2.9×+1.3×

Profitability

See full
Gross margin32.4%+0.2pp
Operating margin8.1%-6.7pp
Net margin3.2%+1.9pp
FCF margin9.9%+3.5pp

Returns & leverage

See full
Return on equity2.2%+1.3pp
Debt / equity0.0×
Current ratio+0.2×

Where this comes from

Reported directly by Rogers Corporation in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Rogers Corporation’s 10-Q, filed July 29, 2026.

Filed
Jul 28, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000084748-26-000048
Line itemJune 30, 2026December 31, 2025
Commitments and contingencies (Note 9)
Shareholders’ equity
Capital stock - $1 par value; 50.0 authorized shares; 17.9 and 17.8 shares issued and outstanding17.917.8
Additional paid-in capital106.3105.7
Retained earnings1,137.41,119.3
Accumulated other comprehensive loss(56.9)(47.1)
Total shareholders' equity1,204.71,195.7
Total liabilities and shareholders' equity$1,446.4$1,429.9

Item 1. Condensed Consolidated Financial Statements (Unaudited):

FAQ

What is Rogers Corporation's total liabilities & equity?
Rogers Corporation (ROG) reported total liabilities & equity of $1.45B in Q2 2026.
How has Rogers Corporation's total liabilities & equity changed year-over-year?
Rogers Corporation's total liabilities & equity decreased by 0.3% year-over-year, from $1.45B to $1.45B.
What is the long-term trend for Rogers Corporation's total liabilities & equity?
Over 5 years (2020 to 2025), Rogers Corporation's total liabilities & equity has grown at a 2.5% compound annual growth rate (CAGR), from $1.26B to $1.43B.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Rogers Corporation's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude